enterovirus
invad
host
cross
intestin
mucosa
line
polar
epithelium
number
enterovirus
includ
echovirus
ev
group
b
coxsackievirus
cvb
initi
infect
attach
decayacceler
factor
daf
molecul
highli
express
apic
surfac
polar
epitheli
cell
previous
observ
entri
dafbind
polar
intestin
epitheli
cell
occur
unusu
endocyt
mechan
requir
caveolin
involv
clathrin
dynamin
examin
entri
dafbind
echoviru
found
drug
small
interf
rna
sirna
domin
neg
mutant
target
factor
requir
clathrinmedi
endocytosi
includ
clathrin
dynamin
inhibit
infect
intern
virion
cell
surfac
viru
enter
cell
coloc
marker
earli
endosom
late
endosom
inhibit
endosom
maturationwith
sirna
domin
neg
mutant
target
infect
prevent
releas
viral
rna
cell
result
indic
intern
clathrinmedi
endocytosi
move
earli
late
endosom
releas
rna
traffick
endosom
known
import
virus
depend
low
ph
endosom
cathepsin
proteas
complet
entri
process
howev
found
infect
requir
neither
low
ph
cathepsin
cellular
cue
requir
releas
viral
rna
enteroviru
capsid
uncoat
remain
poorli
defin
found
move
late
endosom
releas
rna
depend
endosom
matur
nonetheless
depend
endosom
factor
implic
uncoat
entri
virus
result
suggest
either
unidentifi
endosom
factor
essenti
uncoat
traffick
endosom
essenti
step
pathway
lead
anoth
intracellular
organel
uncoat
complet
citat
kim
c
bergelson
jm
echoviru
entri
polar
intestin
epitheli
cell
requir
clathrin
mbio
viral
receptor
induc
conform
chang
viru
capsid
begin
uncoat
process
chang
observ
polioviru
interact
receptor
pvr
coxsackieviru
interact
coxsackieviru
adenoviru
receptor
car
initi
conform
chang
detect
alter
sediment
profil
sucros
gradient
nativ
virion
sediment
alter
particl
sediment
rhinoviru
capsid
unstabl
low
ph
rhinovirus
uncoat
occur
virion
deliv
acid
endosom
howev
enterovirus
transmit
fecalor
rout
must
surviv
exposur
stomach
acid
consequ
capsid
stabl
low
ph
uncoat
appear
independ
endosom
acidif
enterovirus
thought
invad
host
cross
intestin
epithelium
larg
compos
polar
cell
distinct
apic
basolater
surfac
cvb
mani
echovirus
bind
decayacceler
factor
daf
complement
regulatori
molecul
highli
express
apic
surfac
polar
cell
previous
observ
infect
polar
epithelium
bind
daf
cell
surfac
move
tight
junction
enter
cell
unusu
mechan
independ
dynamin
clathrin
requir
caveolin
contact
car
tight
junction
lead
essenti
conform
chang
virion
disrupt
capsid
appear
occur
viru
move
unidentifi
intracellular
compart
unlik
cvb
dafbind
echovirus
requir
car
infect
understand
virus
gain
access
polar
epithelium
examin
entri
dafbind
echoviru
polar
intestin
epitheli
cell
find
intern
clathrinmedi
endocytosi
move
earli
late
endosom
earli
infect
although
uncoat
requir
endosom
acidif
depend
normal
endosom
matur
result
indic
although
bind
cell
surfac
receptor
enter
cell
differ
endocyt
mechan
although
requir
low
ph
uncoat
must
nonetheless
move
late
endosom
uncoat
occur
first
confirm
entri
cell
depend
daf
cell
transfect
small
interf
rna
sirna
target
daf
control
sirna
sirna
target
car
transfect
monolay
expos
viru
depend
daf
car
infect
number
infect
cell
determin
stain
newli
synthes
viral
protein
fig
daf
sirna
inhibit
infect
expect
car
sirna
inhibit
infect
addit
experi
shown
antidaf
monoclon
antibodi
mab
inhibit
bind
radiolabel
cell
inhibit
infect
cell
thu
infect
cell
like
infect
hela
cell
depend
daf
infect
depend
dynamin
clathrin
previous
observ
infect
cell
occur
complex
process
depend
caveolin
appear
independ
clathrinmedi
endocytosi
inhibit
deplet
membran
cholesterol
examin
cellular
factor
requir
infect
use
sirna
domin
neg
dn
mutant
drug
target
clathrinspecif
endocyt
mechan
found
infect
inhibit
sirna
deplet
clathrin
dynamin
fig
domin
neg
mutant
clathrin
adaptor
protein
fig
chlorpromazin
fig
inhibitor
clathrinmedi
endocytosi
dynasor
pharmacolog
inhibitor
dynamin
gtpase
activ
also
mark
inhibitori
effect
infect
fig
small
statist
signific
effect
infect
dynasor
may
nonspecif
inhibit
seen
domin
neg
dynamin
dynamin
sirna
contrast
deplet
sirna
fig
express
domin
neg
caveolin
fig
treatment
cholesteroldeplet
agent
methylbeta
cyclodextrin
fig
inhibit
effect
infect
result
indic
infect
depend
dynamin
clathrin
would
expect
viru
entri
depend
clathrinmedi
endocytosi
entri
depend
dynamin
clathrin
determin
whether
clathrin
dynamin
requir
event
upstream
rna
releas
employ
neutral
red
nr
infecti
center
assay
viru
uncoat
previous
use
studi
polioviru
entri
viru
grown
presenc
nr
dye
concentr
within
capsid
close
proxim
rna
genom
exposur
light
activ
dye
damag
rna
render
viru
noninfecti
howev
uncoat
occur
nr
diffus
away
rna
exposur
light
longer
inhibit
infect
found
plaqu
format
neutral
redlabel
markedli
inhibit
monolay
expos
light
min
major
becam
insensit
light
min
fig
result
suggest
uncoat
larg
occur
min
monitor
requir
uncoat
pretreat
cell
inhibitor
expos
allow
infect
proceed
dark
min
cell
expos
light
harvest
replat
cell
monolay
overlaid
agar
incub
permit
appear
infecti
center
control
nonspecif
effect
inhibitor
parallel
assay
perform
illumin
step
omit
inhibitor
prevent
significantli
delay
cellular
event
upstream
rna
releas
expect
reduc
format
infecti
center
illumin
unillumin
cell
group
preliminari
experi
shown
confirm
uncoat
inhibitor
reduc
infecti
center
format
specif
illumin
cell
previous
shown
polioviru
contrast
brefeldin
act
viru
replic
postentri
step
effect
either
illumin
unillumin
cell
expect
act
stabil
capsid
prevent
convers
nativ
virion
alter
particl
infect
cell
littl
effect
bind
radiolabel
monolay
dynasor
chlorpromazin
significantli
reduc
number
infecti
center
light
exposur
littl
inhibitori
effect
seen
nonillumin
sampl
fig
c
similarli
deplet
dynamin
clathrin
heavi
chain
sirna
specif
reduc
infecti
center
format
illumin
sampl
result
confirm
dynamin
clathrin
requir
event
infect
preced
releas
viral
rna
capsid
test
whether
clathrin
dynamin
requir
intern
virion
viru
surfac
rather
anoth
traffick
event
upstream
rna
releas
test
effect
chlorpromazin
dynasor
intern
virion
directli
conjug
red
fluorophor
cell
pretreat
drug
expos
incub
min
permit
entri
occur
cell
fix
without
permeabil
stain
antibodi
fluorescein
isothiocyan
fitc
label
secondari
antibodi
green
detect
viru
still
expos
cell
surfac
control
cell
treat
dimethyl
sulfoxid
dmso
vehicl
alon
redlabel
viru
seen
accumul
perinuclear
vesicl
inaccess
antibodi
fig
similar
result
seen
cell
treat
uncoat
inhibitor
fig
howev
cell
treat
dynasor
viru
remain
trap
cell
surfac
indic
congruenc
red
green
fluoresc
fig
yellow
cell
treat
chlorpromazin
viru
similarli
trap
transfect
sirna
target
daf
car
control
sirna
label
c
cultur
polar
monolay
expos
describ
materi
method
infect
cell
count
stain
antibodi
nuclei
count
stain
dapi
viru
result
shown
percentag
cell
infect
normal
result
control
sirna
deviat
sd
triplic
sampl
right
immunoblot
confirm
deplet
car
daf
sirna
b
infect
inhibit
sirna
target
dynamin
dyne
clathrin
heavi
chain
chc
sirna
target
caveolin
c
infect
inhibit
domin
neg
form
dynamin
domin
neg
caveolin
polar
monolay
cell
transfect
gfptag
wildtyp
domin
neg
dynamin
caveolin
expos
infect
gfpexpress
cell
count
stain
antibodi
shown
wildtyp
gfpdynamin
effect
infect
compar
gfp
alon
infect
inhibit
dynasor
chlorpromazin
cpz
metylbetacyclodextrin
mcd
result
normal
obtain
control
cell
expos
dmso
carrier
alon
panel
singl
asterisk
indic
p
valu
doubl
asterisk
indic
p
valu
cell
surfac
fig
taken
togeth
data
present
result
indic
entri
infect
depend
intern
virion
clathrinmedi
endocytosi
result
indic
convers
nativ
virion
alter
particl
requir
intern
virion
cell
import
infect
entri
cargo
intern
clathrinmedi
endocytosi
move
rapidli
earli
endosom
cell
peripheri
central
late
endosom
lysosom
endosom
matur
accompani
chang
lipid
protein
content
well
progress
acidif
two
small
gtpase
critic
vesicular
traffic
endosom
system
control
deliveri
cargo
earli
endosom
wherea
regul
matur
late
endosom
endosomelysosom
fusion
begin
character
bound
monolay
unbound
viru
wash
monolay
overlaid
agar
incub
interv
monolay
expos
light
incub
permit
plaqu
develop
b
rna
releas
depend
dynamin
neutral
red
infecti
center
assay
perform
cell
pretreat
dynasor
dmso
label
dyna
dynamin
sirna
describ
materi
method
result
normal
obtain
nonillumin
control
expos
dmso
negativecontrol
sirna
label
c
c
rna
releas
depend
clathrinmedi
endocytosi
neutral
red
infecti
center
assay
perform
cell
pretreat
chlorpromazin
cpz
compar
untreat
control
cell
clathrin
heavi
chain
sirna
chc
compar
cell
treat
control
sirna
cell
expos
redlabel
minut
stain
without
permeabil
antibodi
fitclabel
secondari
antibodi
detect
viru
cell
surfac
viru
red
intern
local
perinuclear
cytoplasm
vesicl
e
cell
treat
dynasor
treat
describ
panel
c
viru
remain
larg
cell
surfac
indic
green
yellow
signal
f
cell
treat
chlorpromazin
viru
remain
larg
cell
surfac
indic
green
yellow
signal
g
cell
treat
tracellular
traffick
event
requir
entri
test
whether
requir
viru
infect
sirna
target
fig
well
domin
neg
form
fig
inhibit
infect
cell
previous
report
infect
inhibit
reagent
target
result
suggest
might
deliv
late
endosom
entri
process
test
examin
coloc
earli
endosom
marker
fig
b
late
endosom
marker
fig
b
interv
infect
coloc
increas
steadili
min
infect
fig
decreas
coloc
increas
slowli
fig
reach
maximum
min
infect
result
suggest
deliv
first
earli
endosom
late
endosom
neutral
red
uncoat
assay
sirna
target
either
inhibit
infecti
center
format
light
exposur
littl
inhibitori
effect
seen
nonillumin
sampl
fig
thu
requir
event
occur
upstream
rna
releas
taken
togeth
result
indic
deliv
late
endosom
uncoat
occur
uncoat
requir
endosom
acidif
cathepsin
activ
number
virus
acidif
endosom
provid
import
trigger
structur
chang
permit
fusion
viral
endosom
membran
releas
nucleic
acid
protein
capsid
rel
mild
acid
earli
endosom
insuffici
deliveri
acid
late
endosom
requir
entri
occur
enterovirus
echoviru
enter
bodi
way
intestin
must
surviv
exposur
gastric
acid
gener
quit
resist
low
ph
test
whether
entri
depend
low
ph
late
endosom
use
two
agent
prevent
endosom
acidif
differ
mechan
ammonium
chlorid
endosom
proton
pump
inhibitor
bafilomycin
neither
ammonium
chlorid
bafilomycin
inhibit
infect
cell
fig
although
agent
effect
block
infect
vesicular
stomat
viru
viru
known
requir
endosom
acidif
fusion
entri
addit
provid
acid
environ
endosom
rich
proteas
endosom
cystein
proteas
primarili
cathepsin
l
b
shown
import
number
virus
includ
reoviru
ebolaviru
murin
hepat
viru
sever
acut
respiratori
syndrom
sar
coronaviru
examin
possibl
role
cathepsin
entri
treat
cell
inhibitor
cathepsin
b
l
concentr
known
inhibit
entri
reoviru
effect
infect
detect
fig
despit
signific
inhibit
cathepsin
b
l
activ
treat
cell
fig
similarli
proteas
inhibitor
shown
wildtyp
effect
infect
compar
gfp
alon
c
rna
releas
neutral
red
infecti
center
assay
perform
cell
pretreat
sirna
target
compar
result
cell
pretreat
negativecontrol
sirna
inhibit
varieti
cystein
proteas
includ
cathepsin
b
l
effect
infect
data
shown
thu
entri
requir
viru
traffick
late
endosom
depend
endosom
acidif
activ
major
endosom
cathepsin
result
report
indic
bind
daf
apic
surfac
polar
epitheli
cell
intern
clathrinmedi
endocytosi
move
earli
late
endosom
releas
rna
cell
drug
sirna
domin
neg
mutant
perturb
clathrinmedi
endocytosi
found
inhibit
infect
intern
virion
cell
surfac
intern
virion
seen
coloc
earli
late
endosom
marker
sirna
domin
neg
mutant
target
rab
gtpase
essenti
endosom
matur
inhibit
infect
act
upstream
rna
releas
like
also
initi
infect
cell
attach
daf
howev
two
virus
use
differ
mechan
entri
entri
requir
viru
interact
car
protein
local
specif
tight
junction
occur
unusu
dynaminindepend
mechan
depend
membran
cholesterol
phosphoryl
caveolin
intern
tight
junction
protein
occludin
among
factor
contrast
intern
depend
host
factor
associ
clathrinmedi
endocytosi
introduct
isol
enterovir
rna
cell
cytoplasm
suffici
initi
infect
thu
critic
event
entri
releas
viral
rna
capsid
cytoplasm
occur
well
understood
polioviru
first
step
uncoat
trigger
virion
interact
receptor
pvr
virion
undergo
conform
chang
lead
exposur
previous
buri
hydrophob
peptid
releas
capsid
small
intern
protein
result
alter
virion
refer
particl
still
retain
rna
genom
second
conform
chang
possibl
intracellular
cue
requir
genom
exit
leav
behind
second
identifi
alter
virion
empti
capsid
contrast
polioviru
interact
pvr
virus
convert
particl
contact
receptor
receptor
minorgroup
rhinovirus
ldl
receptor
induc
conform
chang
instead
mediat
deliveri
acidsuscept
virus
endosom
uncoat
initi
acidif
convert
particl
infect
particl
form
viru
bind
daf
convers
particl
product
infect
depend
interact
anoth
receptor
car
although
bind
human
daf
transfect
rodent
cell
infect
ensu
introduct
nake
viral
rna
cell
result
infect
unpublish
data
suggest
block
infect
occur
upstream
rna
releas
like
note
form
particl
infect
convert
particl
expos
solubl
form
daf
thu
suggest
second
cellular
factor
may
essenti
infect
whether
factor
second
receptor
protein
intracellular
cue
anoth
sort
uncertain
intracellular
site
uncoat
occur
also
remain
question
direct
visual
rna
releas
establish
polioviru
uncoat
hela
cell
occur
rapidli
quit
close
plasma
membran
contrast
indirect
evid
suggest
endotheli
cell
polioviru
uncoat
complet
slowli
viru
move
perinuclear
compart
uncoat
cell
determin
appear
particl
also
occur
deep
within
cell
found
uncoat
defin
neutral
red
assay
complet
approxim
min
viru
coloc
maxim
requir
indic
uncoat
depend
endosom
matur
suggest
late
endosom
environ
may
provid
signal
import
rna
releas
acidif
seem
import
bafilomycin
ammonium
chlorid
effect
infect
although
endosom
cathepsin
import
entri
sever
virus
infect
affect
inhibit
cathepsin
activ
ebolaviru
entri
recent
shown
depend
niemannpick
protein
cholesterol
transport
protein
resid
late
endosom
observ
effect
infect
cell
treat
data
shown
inhibitor
cholesterol
synthesi
induc
cellular
phenotyp
similar
seen
niemannpick
defici
shown
block
ebola
viru
entri
thu
specif
endosom
factor
requir
uncoat
remain
identifi
observ
must
reach
late
endosom
uncoat
unexpect
enteroviru
depend
endosom
acidif
data
show
directli
uncoat
occur
late
endosom
exclud
possibl
traffick
endosom
essenti
step
pathway
lead
anoth
intracellular
organel
uncoat
complet
case
move
endosom
way
endoplasm
reticulum
er
destabil
capsid
catalyz
factor
present
er
lumen
current
explor
whether
entri
depend
addit
host
factor
associ
specif
aspect
endosom
matur
traffick
late
endosom
intracellular
compart
cell
atcc
cultur
high
glucos
minim
essenti
medium
contain
fetal
bovin
serum
marchapril
volum
issu
nonessenti
amino
acid
penicillinstreptomycin
chines
hamster
ovari
cho
cell
stabli
transfect
cdna
encod
human
car
human
daf
empti
vector
describ
previous
echoviru
wallac
atcc
prepar
hela
cell
concentr
ultracentrifug
sucros
cushion
titer
plaqu
assay
hela
cell
vesicular
stomat
viru
provid
ron
harti
univers
pennsylvania
prepar
titer
determin
cell
describ
antibodi
chemic
carspecif
rabbit
polyclon
antibodi
horseradish
peroxidas
hrp
conjug
gapdh
antibodi
catalog
obtain
santa
cruz
biotechnolog
murin
monoclon
antibodi
specif
daf
catalog
clathrin
heavi
chain
catalog
caveolin
catalog
antibodi
catalog
obtain
bd
rabbit
polyclon
antibodi
specif
dynamin
abcam
catalog
rabbit
polyclon
stressgen
catalog
rabbit
polyclon
sigma
catalog
murin
monoclon
antibodi
specif
clone
development
studi
hybridoma
bank
univers
iowa
monoclon
antibodi
specif
vesicular
stomat
viru
vsv
protein
clone
obtain
dougla
lyle
wake
forest
univers
dynasor
bafilomycin
cathepsin
b
inhibitor
catalog
cathepsin
l
inhibitor
catalog
obtain
calbiochem
chlorpromazin
cpz
methylbetacyclodextrin
nh
cl
sigma
compound
provid
janssen
pharmaceut
plasmid
sirna
plasmid
encod
green
fluoresc
protein
gfp
tag
wildtyp
wt
domin
neg
dn
dynamin
provid
mark
mcniven
mayo
institut
rochest
ms
gfptag
wt
dn
caveolin
ari
heleniu
swiss
feder
institut
technolog
zurich
wt
dn
provid
alic
dautryvarsat
institut
pasteur
pari
gfptag
wt
dn
provid
georg
bloom
univers
virginia
wt
dn
provid
craig
roy
yale
univers
transfect
plasmid
perform
use
amaxa
nucleofector
system
lonza
transfect
cell
plate
cellswel
collagenco
chamber
slide
bd
use
viru
infect
day
control
human
car
sirna
describ
previous
sequenc
daf
sirna
gua
cca
ggu
ggc
aua
uua
utt
sirna
target
dynamin
clathrin
heavi
chain
purchas
dharmacon
sirna
agg
aau
cag
ugu
ugu
agu
att
gaa
agu
caa
gcc
ugg
uau
utt
caa
uga
acg
uga
acg
aaa
utt
synthes
base
sequenc
previou
report
sirna
purchas
santa
cruz
sirna
target
use
nm
concentr
sirna
use
nm
transfect
perform
lipofectamin
invitrogen
cell
transfect
plate
optim
knockdown
effici
second
transfect
perform
h
first
addit
h
monolay
trypsin
cell
replat
cellswel
collagenco
chamber
slide
bd
bioscienc
infect
perform
day
later
deplet
target
protein
confirm
immunoblot
analysi
parallel
sampl
viru
infect
intern
cell
plate
collagenco
chamber
slide
bd
bioscienc
cell
per
well
infect
day
later
measur
infect
viru
vsv
pfucel
minimum
essenti
medium
mem
mm
hepe
permit
bind
polar
monolay
h
monolay
wash
phosphatebuff
salin
pb
complet
medium
ad
cell
incub
h
infect
termin
fixat
permeabil
min
mixtur
icecold
methanolaceton
monolay
stain
antibodi
nclentero
novocastra
detect
infect
cell
dapi
detect
cell
nuclei
imag
captur
olympu
immunofluoresc
microscop
use
object
three
four
field
cell
captur
monolay
number
infect
cell
total
number
dapistain
nuclei
quantifi
use
imagej
softwar
http
rsbwebnihgovij
entri
stain
purifi
sucros
gradient
label
molar
excess
alexafluor
succinamidyl
ester
molecular
probe
use
protocol
previous
describ
label
pfucel
allow
bind
cell
h
pfucel
pb
wash
complet
medium
ad
cell
incub
min
viru
intern
stop
fixat
paraformaldehyd
pfa
min
excess
pfa
remov
pb
contain
mm
nh
cl
surfaceassoci
viru
detect
stain
unpermeabil
monolay
antibodi
antimous
secondari
antibodi
conjug
fitc
slide
mount
vectashield
vector
laboratori
imag
captur
zeiss
lsm
confoc
microscop
use
oil
object
zstack
imag
obtain
interv
view
lsm
reader
plugin
imagej
inhibitori
drug
use
follow
concentr
dynasor
bafilomycin
nm
cathepsin
b
inhibitor
cathepsin
l
inhibitor
chlorpromazin
gml
mm
nh
cl
mm
brefeldin
gml
gml
gener
see
except
cell
pretreat
min
complet
medium
contain
drug
viru
permit
bind
drugcontain
medium
h
unbound
viru
remov
drugcontain
medium
replac
infect
allow
proceed
h
experi
dynasor
medium
nuserum
bd
bioscienc
bedford
place
fetal
bovin
serum
fb
use
serum
compon
decreas
efficaci
drug
experi
dynasor
drugcontain
medium
replac
normal
medium
h
act
quickli
deplet
cholesterol
plasma
membran
cell
pretreat
min
drug
use
cours
infect
neutral
red
infecti
center
assay
uncoat
assay
prepar
neutral
red
nr
label
viru
hela
cell
infect
pfucel
presenc
gml
nr
overnight
incub
viru
harvest
purifi
dark
neutral
red
infecti
center
assay
use
inhibitor
drug
sirna
perform
describ
brandenburg
et
al
slight
modif
experi
sirna
cell
transfect
allow
form
polar
monolay
plate
infect
experi
drug
monolay
plate
pretreat
drug
h
dark
bind
buffer
contain
drug
allow
attach
cell
h
bind
buffer
remov
infect
initi
ad
warm
cultur
medium
contain
drug
appropri
min
virusinfect
cell
expos
white
light
min
room
temperatur
preliminari
experi
indic
incub
requir
major
input
viru
escap
lightinduc
nr
damag
duplic
monolay
maintain
dark
use
unillumin
control
cell
detach
trypsinedta
count
dilut
replat
onto
fresh
monolay
plate
absenc
inhibitor
agaros
overlay
ad
h
day
plaqu
develop
count
four
independ
experi
number
plaqu
drugtreat
illumin
well
normal
number
plaqu
unillumin
control
well
express
percentag
therefor
error
estim
provid
control
defin
capsid
conform
chang
convers
nativ
virion
particl
detect
essenti
describ
refer
monolay
incub
radiolabel
unbound
viru
remov
cell
either
maintain
cold
incub
either
presenc
dmso
alon
min
cell
lyse
debri
remov
recov
viru
subject
centrifug
sucros
gradient
coloc
endosom
marker
monolay
incub
interv
monolay
fix
mixtur
icecold
methanolaceton
stain
antibodi
specif
follow
fitcconjug
secondari
antibodi
examin
confoc
microscopi
imag
best
focu
red
viru
channel
captur
analyz
exclud
nonintern
viru
cytoplasm
region
cell
outlin
freehand
select
tool
imagej
coloc
red
green
signal
determin
use
coloc
test
plugin
wcif
imagej
bundl
calcul
pearson
correl
coeffici
cell
three
independ
experi
perform
experi
least
five
imag
analyz
time
point
measur
cathepsin
b
l
activ
cathepsin
activ
measur
describ
ebert
et
al
slight
modif
cell
preincub
cathepsin
b
l
inhibitor
h
wash
pb
lyse
mm
sodium
acet
ph
mm
edta
triton
insolubl
debri
remov
cell
lysat
mix
cathepsin
b
substrat
calbiochem
catalog
incub
min
room
temperatur
cathepsin
l
substrat
invitrogen
catalog
incub
h
cathepsin
b
activ
fluoresc
measur
use
multimod
micropl
reader
biotek
excit
nm
emiss
nm
cathepsin
l
activ
fluoresc
measur
use
fluostar
fluoromet
bmg
labtechnolog
excit
nm
emiss
nm
analysi
experiment
variat
figur
error
bar
indic
mean
standard
deviat
independ
sampl
singl
asterisk
indic
p
valu
determin
student
test
doubl
asterisk
indic
p
valu
